ebomi
Colour theme
Sign in
Insider · CIK 0001283304

Xanthopoulos Kleanthis G

CIK 0001283304 Name as filed on the most recent filing

Filed as Xanthopoulos Kleanthis G (43)

206 transaction lines · from 43 filings · filed 2005-06-23 to 2016-08-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

206 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2016-08-19 Zosano Pharma Corp
ZSAN 		P, Open-market purchase 15,920 acquired 1.32 21,014.40 Form 4, filing 0001587221-16-000005
2015-04-21 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 60,000 disposed 17.73 1,063,980.00 Form 4, filing 0001209191-15-035362
2015-04-20 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 66,071 disposed 16.85 1,113,514.38 Form 4, filing 0001209191-15-035362
2015-04-17 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 73,929 disposed 16.94 1,252,002.40 Form 4, filing 0001209191-15-035362
2015-03-05 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 65,614 disposed 20.06 1,316,512.10 Form 4, filing 0001209191-15-023195
2015-03-05 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 23,616 disposed 20.81 491,550.51 Form 4, filing 0001209191-15-023195
2015-02-27 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 70 disposed 19.50 1,365.00 Form 4, filing 0001209191-15-021532
2015-02-02 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 2,400 disposed 19.77 47,440.08 Form 4, filing 0001209191-15-009000
2015-01-30 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 3,300 disposed 19.50 64,351.32 Form 4, filing 0001209191-15-009000
2015-01-29 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 33,773 disposed 17.77 600,007.74 Form 4, filing 0001209191-15-007971
2015-01-29 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 26,227 disposed 18.40 482,626.63 Form 4, filing 0001209191-15-007971
2015-01-28 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 72,011 disposed 17.97 1,293,814.44 Form 4, filing 0001209191-15-007971
2015-01-28 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 12,989 disposed 18.69 242,700.76 Form 4, filing 0001209191-15-007971
2014-10-29 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 2,005 disposed 19.78 39,658.90 Form 4, filing 0001209191-14-065583
2014-10-29 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 1,400 disposed 18.66 26,124.00 Form 4, filing 0001209191-14-065583
2014-10-29 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 100 disposed 20.41 2,041.00 Form 4, filing 0001209191-14-065583
2014-10-20 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 300 disposed 7.00 2,100.00 Form 4, filing 0001209191-14-064146
2014-10-17 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 400 disposed 7.04 2,816.00 Form 4, filing 0001209191-14-064146
2014-10-14 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 400 disposed 7.00 2,800.00 Form 4, filing 0001209191-14-063130
2014-10-09 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 105 disposed 7.00 735.00 Form 4, filing 0001209191-14-063130
2014-09-30 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 2,300 disposed 7.02 16,137.49 Form 4, filing 0001209191-14-061263
2014-08-28 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 3,505 disposed 7.06 24,754.41 Form 4, filing 0001209191-14-055078
2014-08-05 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 3,505 disposed 7.06 24,739.34 Form 4, filing 0001209191-14-051215
2014-07-01 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 3,505 disposed 8.11 28,425.55 Form 4, filing 0001209191-14-045260
2014-06-09 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 3,505 disposed 7.14 25,017.29 Form 4, filing 0001209191-14-039996
2014-05-29 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 887 disposed 7.00 6,209.00 Form 4, filing 0001209191-14-037812
2014-05-28 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 875 disposed 7.00 6,125.96 Form 4, filing 0001209191-14-037812
2014-05-27 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 1,743 disposed 7.00 12,202.92 Form 4, filing 0001209191-14-037812
2014-03-06 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 3,505 disposed 11.35 39,778.24 Form 4, filing 0001209191-14-018179
2014-03-06 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 3,505 disposed 7.60 26,622.93 Form 4, filing 0001209191-14-026601
2014-02-05 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 3,505 disposed 8.40 29,437.44 Form 4, filing 0001209191-14-008312
2014-01-02 Regulus Therapeutics Inc.
RGLS 		S, Open-market sale 3,505 disposed 7.25 25,408.45 Form 4, filing 0001209191-14-000372
2013-12-26 Apricus Biosciences, Inc.
APRI 		S, Open-market sale 17,184 disposed 2.55 43,819.20 Form 4, filing 0001181431-13-064642
2013-06-21 Apricus Biosciences, Inc.
APRI 		S, Open-market sale 2,864 disposed 2.52 7,217.28 Form 4, filing 0001181431-13-036351
2013-05-21 Apricus Biosciences, Inc.
APRI 		S, Open-market sale 2,864 disposed 3.36 9,612.73 Form 4, filing 0001181431-13-030396
2013-04-22 Apricus Biosciences, Inc.
APRI 		S, Open-market sale 2,864 disposed 2.63 7,523.73 Form 4, filing 0001181431-13-023075
2013-03-21 Apricus Biosciences, Inc.
APRI 		S, Open-market sale 2,864 disposed 2.50 7,160.00 Form 4, filing 0001181431-13-018345
2012-09-28 Apricus Biosciences, Inc.
APRI 		S, Open-market sale 3,125 disposed 3.25 10,158.12 Form 4, filing 0001144204-12-054091
2012-08-15 Apricus Biosciences, Inc.
APRI 		S, Open-market sale 12,500 disposed 3.01 37,683.75 Form 4, filing 0001144204-12-046893
2007-08-16 Anadys Pharmaceuticals Inc
ANDS 		P, Open-market purchase 6,500 acquired 2.15 13,957.45 Form 4, filing 0001209191-07-048895
2006-11-14 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 100 disposed 5.00 500.00 Form 4, filing 0001209191-06-059639
2006-06-19 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 5,300 disposed 7.00 37,100.00 Form 4, filing 0001209191-06-037512
2006-06-19 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 1,400 disposed 6.99 9,786.00 Form 4, filing 0001209191-06-037512
2006-06-19 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 1,100 disposed 7.01 7,711.00 Form 4, filing 0001209191-06-037512
2006-06-19 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 700 disposed 7.01 4,907.00 Form 4, filing 0001209191-06-037512
2006-06-19 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 300 disposed 7.00 2,100.00 Form 4, filing 0001209191-06-037512
2006-06-19 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 200 disposed 6.97 1,394.00 Form 4, filing 0001209191-06-037512
2006-05-15 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 2,176 disposed 10.52 22,891.52 Form 4, filing 0001209191-06-030802
2006-05-15 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 800 disposed 10.48 8,384.00 Form 4, filing 0001209191-06-030802
2006-05-15 Anadys Pharmaceuticals Inc
ANDS 		S, Open-market sale 700 disposed 10.51 7,357.00 Form 4, filing 0001209191-06-030802

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 204
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. XANTHOPOULOS KLEANTHIS G, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001283304

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.